Cargando…

Leveraging South African HIV research to define SARS‐CoV‐2 immunity triggered by sequential variants of concern

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus that causes coronavirus disease 2019 (COVID‐19), has shifted our paradigms about B cell immunity and the goals of vaccination for respiratory viruses. The development of population immunity, through responses directed to highly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhiman, Jinal N., Moore, Penny L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Invited Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349367/ https://www.ncbi.nlm.nih.gov/pubmed/35599324 http://dx.doi.org/10.1111/imr.13086

Ejemplares similares

Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2013)

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
por: Bhiman, Jinal N., et al.
Publicado: (2023)

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2021)

Leveraging systems biology approaches in clinical pharmacology
por: Melas, Ioannis N, et al.
Publicado: (2013)

Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineage
por: Sacks, David, et al.
Publicado: (2019)

Ontogeny‐based immunogens for the induction of V2‐directed HIV broadly neutralizing antibodies
por: Moore, Penny L., et al.
Publicado: (2017)

Leveraging single‐cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers
por: Bowes, Amy L, et al.
Publicado: (2022)

Invited Perspective: Leveraging Air Quality Research Advancements to Assess and Address Exposure Inequities
por: Goldman, Gretchen T.
Publicado: (2023)

Leveraging Telemedicine for Chronic Disease Management in Low- and Middle-Income Countries During Covid-19
por: Hoffer-Hawlik, Michael A., et al.
Publicado: (2020)

Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant
por: Ryu, Dong-Kyun, et al.
Publicado: (2021)

SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron’s impact in South African population cohorts
por: Sun, Kaiyuan, et al.
Publicado: (2022)

Trastuzumab in the adjuvant setting: concurrent or sequential? It takes two to tango!
por: Verma, Sunil
Publicado: (2008)

Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System
por: Bhiman, Jinal N., et al.
Publicado: (2017)

Comment on Project THANKS: Examining HIV/AIDS-Related Barriers and Facilitators to Care in African American Women: A Community Perspective
por: Amutah-Onukagha, Ndidiamaka, et al.
Publicado: (2020)

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
por: Bhiman, Jinal N., et al.
Publicado: (2015)

Gender Diversity in Orthopedics—New Insights and Ongoing Concerns
por: O’Connor, Megan, et al.
Publicado: (2023)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

Defining Aging in Place: The Intersectionality of Space, Person, and Time
por: Rogers, Wendy A, et al.
Publicado: (2020)

Macrophage subsets in atherosclerosis as defined by single‐cell technologies
por: Willemsen, Lisa, et al.
Publicado: (2020)

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)
por: Koen, Anthonet L., et al.
Publicado: (2023)

A Thermostable Cas12b from Brevibacillus Leverages One-pot Detection of SARS-CoV-2 Variants of Concern
por: Nguyen, Long T., et al.
Publicado: (2021)

A thermostable Cas12b from Brevibacillus leverages one-pot discrimination of SARS-CoV-2 variants of concern
por: Nguyen, Long T., et al.
Publicado: (2022)

An overview of genetic variants regarding efavirenz‐related dysthymias in HIV‐infected patients: Response to a letter to the editor
por: Hosseini, Zahra, et al.
Publicado: (2022)

New models for defining prostate cancer biology and patient prognosis
por: Brundage, James, et al.
Publicado: (2021)

Leveraging Novel Integrated Single-Cell Analyses to Define HIV-1 Latency Reversal
por: Zhao, Suhui, et al.
Publicado: (2021)

Native‐like Env trimers as a platform for HIV‐1 vaccine design
por: Sanders, Rogier W., et al.
Publicado: (2017)

Defining and Implementing Value-Based Health Care: A Strategic Framework
por: Teisberg, Elizabeth, et al.
Publicado: (2020)

COVID-19 as a catalyst for vaccine manufacturing: A South African experience
por: Moore, Penny L., et al.
Publicado: (2023)

Transfusion Triggers for Platelets and Other Blood Products
por: Karanth, Sunil
Publicado: (2019)

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth
por: Sheward, Daniel J., et al.
Publicado: (2018)

Right ventricle to pulmonary artery shunt modification of Norwood procedure: Outcomes, concerns, and controversies
por: Raja, Shahzad G
Publicado: (2011)

Leveraging the South African Diabetes Prevention Programme to screen for chronic kidney disease: an observational study
por: George, Cindy, et al.
Publicado: (2023)

Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa
por: Meiring, Susan, et al.
Publicado: (2022)

Defining the South African Acute Respiratory Infectious Disease Season
por: Motlogeloa, Ogone, et al.
Publicado: (2023)

Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease
por: Chastain, Emily M. L., et al.
Publicado: (2012)

Comparison of the neutralization sensitivity of South African and Indian HIV-1 subtype C viruses to South African plasma antibodies
por: Hermanus, T, et al.
Publicado: (2012)

Sports cardiology: A glorious past, a well‐defined present, a bright future
por: D'Ascenzi, Flavio, et al.
Publicado: (2023)

Epidemiological, serological, and genetic evidence of influenza D virus infection in humans: Is it a justifiable cause for concern?
por: Vega-Rodriguez, Widaliz, et al.
Publicado: (2023)

Re-defininG AddiC(CH3)Tion: genomics and epigenomics on substance use disorders
por: Rutter, Joni L, et al.
Publicado: (2014)

Defining urge as an uncontrolled micturition explains pathogenesis, informs cure and helps solve the burgeoning OAB crisis
por: Petros, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_le6bt3eo4a53tltfj1iv6m7d5m